GOP lawmakers in Wisconsin have a track record of opposing efforts to reform marijuana laws in the Badger State, but a recent comment from Assembly Speaker Robin Vos has some marijuana advocates hopeful for progress during the 2017 legislative session.
“If you get a prescription to use an opiate or you get a prescription to use marijuana, to me I think that’s the same thing,” Vos said, a surprising position after years of GOP opposition to legalizing any form of marijuana. “I would be open to that.”
Of course this came as a surprise to many, especially after Senate Majority Leader Scott Fitzgerald and Governor Scott Walker have both repeatedly stated that they will continue to oppose any effort to advance the issue in the state of Wisconsin. Regardless of the lack of support from GOP leadership, Sen. Van Wanggaard is expected to sponsor legislation that would make it legal to possess cannibidiol (CBD) – the marijuana extract known for treating seizures associated with epilepsy – during the upcoming legislative session.
Officials in the Village of Oswego, Illinois recently passed an ordinance that allows local law enforcement to issue tickets and fines to anyone found with small amounts of marijuana or certain drug paraphernalia. For example, if a person is in possession of drug paraphernalia and is convicted of possessing 10 grams or less of marijuana, the charge for the paraphernalia is now considered a civil law violation, punishable by a minimum fine of $100 and a maximum fine of $200.
Marijuana-related offenses became civil violations after the Illinois state legislature voted to amended the Cannabis Control Act in 2016, but it is up to local governments to amend their local marijuana laws to reflect the change at the state level.
“Oswego’s fines will begin at $100 for the first offense and $150 and $250 for second and third offenses. There is a maximum $750 penalty for repeat violators,” said Oswego Police Chief Jeff Burgner.
The City of Yorkville adopted a similar ordinance in October.
Read more here: http://www.chicagotribune.com/suburbs/aurora-beacon-news/news/ct-abn-oswego-marijuana-st-0105-20170104-story.html
Members of Congress have re-authorized a federal provision prohibiting the Justice Department from interfering in state-authorized medical cannabis programs. The provision, known as the Rohrabacher-Farr amendment, was included in short-term spending legislation, House Resolution 2028, and will expire on April 28, 2017.
Initially enacted by Congress in 2014, the amendment maintains that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.” In August, the Ninth Circuit Court of Appeals unanimously ruled that the language bars the federal government from taking legal action against any individual involved in medical marijuana-related activity absent evidence that the defendant is in clear violation of state law.
Because the provision is included as part of a Congressional spending package and does not explicitly amend the US Controlled Substances Act, members must re-authorize the amendment annually. However, House leadership may prohibit federal lawmakers from revisiting the issue when they craft a longer-term funding bill this spring. Such a change in House rules would require members of the Senate to pass an equivalent version of the legislation, which would then need to be approved by House leaders in conference committee.
Looking ahead to 2017, marijuana law reforms face an uncertain future. Therefore, it is more important than ever that this federal protection remains in place to ensure that these patient programs and those who rely upon them are not subject to federal interference.
According to the Associated Press, voters in Montana have approved Initiative 182, the Montana Medical Marijuana Initiative. The Associated Press’s final vote count is 58 to 42 percent.
“This decision restores the rights of patients and providers,” said NORML Deputy Director Paul Armentano. “Voters were clear in 2004 when they initially enacted the state’s medical law, and they remain resolved in their opinion that state lawmakers ought not to restrict patients access to medical cannabis.”
I-182 expands the state’s medical marijuana laws. It permits licensed medical marijuana providers to serve more than three patients at one time and allows for providers to hire employees to cultivate, dispense, and transport medical marijuana. I-182 repeals the requirement that physicians who provide certifications for 25 or more patients annually be referred to the board of medical examiners. It removes the authority of law enforcement to conduct unannounced inspections of medical marijuana facilities, and requires annual inspections by the state.
The new law takes effect on June 30, 2017. You can read the full text of the initiative here.
According to the Associated Press, voters in Arkansas have approved Issue 6, the Arkansas Medical Marijuana Amendment. The AP’s final vote count is 53 to 47 percent.
“Thanks to the support of Arkansas voters, their state now joins the majority of states in this country in allowing for the medicinal use of marijuana. This will provide patients with access to a safe and effective medicine and apply further pressure on Congress and the incoming administration to bring federal policy in line with the overwhelming will of the American people.” said Erik Altieri, NORML’s new Executive Director.
Issue 6, the Arkansas Medical Marijuana Amendment, amends the state constitution to permit qualified patients who possess a physician’s recommendation may legally possess and obtain medical cannabis provided by state licensed dispensaries. The home cultivation of cannabis is not permitted under the law. Under the law, regulators will license up to 40 dispensary providers and up to eight marijuana cultivators.
The new law takes effect on November 9, 2016. Regulators have 120 days following the law’s enactment to develop rules overseeing the new medical marijuana program.
A summary of the Amendment is available here.